Abivax Société Anonyme
(NASDAQ) ABVX
Abivax Société Anonyme Financials at a Glance
Market Cap
$8.67B
Revenue (TTM)
$15.13M
Net Income (TTM)
$331.99M
EPS (TTM)
$-5.41
P/E Ratio
-20.25
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Price
$102.53
Volume
122,770
Open
$108.38
Price
$102.53
Volume
122,770
Open
$108.38
Previous Close
$102.53
Daily Range
$102.00 - $108.39
52-Week Range
$4.77 - $148.83
Dividend
$0.00
Beta (Volatility)
0.78 (Low)
Price
$102.53
Volume
122,770
Open
$108.38
Previous Close
$102.53
Daily Range
$102.00 - $108.39
52-Week Range
$4.77 - $148.83
ABVX News
Why Abivax Stock Was on Fire Today
ABVX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Abivax Société Anonyme
Industry
Biotechnology
Sector
Health CareEmployees
69
CEO
Marc M. P. de Garidel, EMBA
Website
www.abivax.comHeadquarters
Paris, 75008, FR
ABVX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-33%
Net Income Margin
-32%
Return on Equity
-147%
Return on Capital
-27%
Return on Assets
-2%
Earnings Yield
-4.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.67B
Shares Outstanding
79.17M
Volume
122.77K
Short Interest
0.00%
Avg. Volume
1.24M
Financials (TTM)
Gross Profit
$10.79M
Operating Income
$172.98M
EBITDA
$171.88M
Operating Cash Flow
$154.07M
Capital Expenditure
$643.00K
Free Cash Flow
$154.72M
Cash & ST Invst.
$144.22M
Total Debt
$97.36M
Abivax Société Anonyme Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$2.02M
-10.3%
Gross Profit
$2.02M
-10.3%
Gross Margin
100.00%
N/A
Market Cap
$8.67B
N/A
Market Cap/Employee
$125.61M
N/A
Employees
69
N/A
Net Income
$100.78M
-94.0%
EBITDA
$93.59M
-138.7%
Quarterly Fundamentals
Net Cash
$23.63M
-129.6%
Accounts Receivable
$14.74M
+16.1%
Inventory
$0.00
N/A
Long Term Debt
$35.73M
+42.7%
Short Term Debt
$48.84M
+405.9%
Return on Assets
-1.63%
N/A
Return on Invested Capital
-27.32%
N/A
Free Cash Flow
$66.68M
-130.0%
Operating Cash Flow
$66.62M
-141.4%